Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Sarmiento

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Primary nongestational choriocarcinoma of the uterine cervixRaffaele Longo, Francesco Battaglia, Domenico Gattuso, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antiangiogenic agentsSimonetta Chiara Stani, Barbara Capaccetti, Paola Bonginelli, et al.
Clinical Breast Cancer|March 15, 2003
Prognostic and predictive indicators in operable breast cancerAlessandro Morabito, Elena Magnani, Massimo Gion, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Thalidomide: a new anticancer drug?Massimo Fanelli, Roberta Sarmiento, Domenico Gattuso, et al.
The Oncologist|October 27, 2005
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancerGiampietro Gasparini, Domenico Gattuso, Alessandro Morabito, et al.
Breast Cancer Research and Treatment|November 30, 2004
Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancerAlessandro Morabito, Domenico Gattuso, Simonetta Chiara Stani, et al.
Gut|March 28, 2015
Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancerAlexander Hamm, Hans Prenen, Wouter Van Delm, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Primary nongestational choriocarcinoma of the uterine cervixRaffaele Longo, Francesco Battaglia, Domenico Gattuso, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
Antiangiogenic agentsSimonetta Chiara Stani, Barbara Capaccetti, Paola Bonginelli, et al.
Clinical Breast Cancer|March 15, 2003
Prognostic and predictive indicators in operable breast cancerAlessandro Morabito, Elena Magnani, Massimo Gion, et al.
Expert Opinion on Investigational Drugs|July 2, 2003
Thalidomide: a new anticancer drug?Massimo Fanelli, Roberta Sarmiento, Domenico Gattuso, et al.
The Oncologist|October 27, 2005
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancerGiampietro Gasparini, Domenico Gattuso, Alessandro Morabito, et al.
Breast Cancer Research and Treatment|November 30, 2004
Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancerAlessandro Morabito, Domenico Gattuso, Simonetta Chiara Stani, et al.
Gut|March 28, 2015
Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancerAlexander Hamm, Hans Prenen, Wouter Van Delm, et al.
Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 15, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease RecurrencePatricia Gomez-Rosas, Marina Pesenti, Cristina Verzeroli, et al.
Pageof 3